179 related articles for article (PubMed ID: 34126110)
1. Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation.
Del Bello A; Kamar N; Vergez F; Faguer S; Marion O; Beq A; Lathrache Y; Abravanel F; Izopet J; Treiner E
Kidney Int; 2021 Oct; 100(4):915-927. PubMed ID: 34126110
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive assessment of long-term SARS-CoV-2-specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients.
Favà A; Donadeu L; Jouve T; Gonzalez-Costello J; Lladó L; Santana C; Toapanta N; Lopez M; Pernin V; Facundo C; Cabañas NS; Thaunat O; Crespo M; Llinàs-Mallol L; Revuelta I; Sabé N; Rombauts A; Calatayud L; Ardanuy C; Esperalba J; Fernandez C; Lozano JJ; Preyer R; Strecker K; Couceiro C; García-Romero E; Cachero A; Meneghini M; Torija A; Le Quintrec M; Melilli E; Cruzado JM; Polo C; Moreso F; Crespo E; Bestard O
Kidney Int; 2022 May; 101(5):1027-1038. PubMed ID: 35124011
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.
Pereira MR; Mohan S; Cohen DJ; Husain SA; Dube GK; Ratner LE; Arcasoy S; Aversa MM; Benvenuto LJ; Dadhania DM; Kapur S; Dove LM; Brown RS; Rosenblatt RE; Samstein B; Uriel N; Farr MA; Satlin M; Small CB; Walsh TJ; Kodiyanplakkal RP; Miko BA; Aaron JG; Tsapepas DS; Emond JC; Verna EC
Am J Transplant; 2020 Jul; 20(7):1800-1808. PubMed ID: 32330343
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection in Pediatric Solid Organ Transplant Recipients: A Single Center Observation.
Paul S; Royal S; Lee M; Shin S; Chahine J; Rozeboom A; Ahn J; Dhani H; Yazigi N; Kaufman S; Khan K; Matsumoto C; Kroemer A; Fishbein T; Ekong UD
J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):276-285. PubMed ID: 35758426
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features of SARS-CoV-2 Infection in Patients Undergoing Solid-Organ Transplant: Baskent University Experience.
Darılmaz Yüce G; Ulubay G; Tek K; Savaş Bozbaş Ş; Erol Ç; Büyükaşık P; Haberal KM; Arslan AH; Akçay MŞ; Haberal M
Exp Clin Transplant; 2023 May; 21(5):451-459. PubMed ID: 34635037
[TBL] [Abstract][Full Text] [Related]
6. Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort.
Avery RK; Chiang TP; Marr KA; Brennan DC; Sait AS; Garibaldi BT; Shah P; Ostrander D; Steinke SM; Permpalung N; Cochran W; Makary MA; Garonzik-Wang J; Segev DL; Massie AB
Am J Transplant; 2021 Jul; 21(7):2498-2508. PubMed ID: 33284498
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients.
Sarrell BA; Bloch K; El Chediak A; Kumm K; Tracy K; Forbes RC; Langone A; Thomas L; Schlendorf K; Trindade AJ; Perri R; Wright P; Concepcion BP
Transpl Infect Dis; 2022 Feb; 24(1):e13759. PubMed ID: 34787345
[TBL] [Abstract][Full Text] [Related]
8. Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled?
NasrAllah MM; Osman NA; Elalfy M; Malvezzi P; Rostaing L
Rev Med Virol; 2021 Jan; 31(1):1-9. PubMed ID: 32954602
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response.
Alberici F; Affatato S; Moratto D; Mescia F; Delbarba E; Guerini A; Tedesco M; Burbelo PD; Zani R; Castagna I; Gallico A; Tonoli M; Venturini M; Roccaro AM; Giacomelli M; Cohen JI; Giustini V; Dobbs K; Su HC; Fiorini C; Quaresima V; Viola FB; Vizzardi V; Gaggiotti M; Bossini N; Gaggia P; Badolato R; Notarangelo LD; Chiarini M; Scolari F
J Nephrol; 2022 Apr; 35(3):745-759. PubMed ID: 35067905
[TBL] [Abstract][Full Text] [Related]
11. Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies.
Candel FJ; Salavert M; Lorite Mingot D; Manzano Crespo M; Pérez Portero P; Cuervo Pinto R
Rev Esp Quimioter; 2023 Aug; 36(4):380-391. PubMed ID: 37089055
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection.
Burack D; Pereira MR; Tsapepas DS; Harren P; Farr MA; Arcasoy S; Cohen DJ; Mohan S; Emond JC; Hod EA; Verna EC
Am J Transplant; 2021 Jun; 21(6):2254-2261. PubMed ID: 33590675
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated.
Heldman MR; Kates OS; Fisher CE; Limaye AP
Transpl Infect Dis; 2021 Aug; 23(4):e13650. PubMed ID: 34325492
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study.
Pereira MR; Arcasoy S; Farr MA; Mohan S; Emond JC; Tsapepas DS; Shi Q; Purpura L; Uhlemann AC; Zucker J; Verna EC
Transpl Infect Dis; 2021 Aug; 23(4):e13637. PubMed ID: 33993630
[TBL] [Abstract][Full Text] [Related]
15. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
Al Jurdi A; Morena L; Cote M; Bethea E; Azzi J; Riella LV
Am J Transplant; 2022 Dec; 22(12):3130-3136. PubMed ID: 35727916
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study.
Kates OS; Haydel BM; Florman SS; Rana MM; Chaudhry ZS; Ramesh MS; Safa K; Kotton CN; Blumberg EA; Besharatian BD; Tanna SD; Ison MG; Malinis M; Azar MM; Rakita RM; Morilla JA; Majeed A; Sait AS; Spaggiari M; Hemmige V; Mehta SA; Neumann H; Badami A; Goldman JD; Lala A; Hemmersbach-Miller M; McCort ME; Bajrovic V; Ortiz-Bautista C; Friedman-Moraco R; Sehgal S; Lease ED; Fisher CE; Limaye AP;
Clin Infect Dis; 2021 Dec; 73(11):e4090-e4099. PubMed ID: 32766815
[TBL] [Abstract][Full Text] [Related]
17. Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.
Hartzell S; Bin S; Benedetti C; Haverly M; Gallon L; Zaza G; Riella LV; Menon MC; Florman S; Rahman AH; Leech JM; Heeger PS; Cravedi P
Am J Transplant; 2020 Nov; 20(11):3149-3161. PubMed ID: 32786152
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.
Perrier Q; Lupo J; Gerster T; Augier C; Falque L; Rostaing L; Pelletier L; Bedouch P; Blanc M; Saint-Raymond C; Boignard A; Bonadona A; Noble J; Epaulard O
Vaccine; 2022 Oct; 40(44):6404-6411. PubMed ID: 36184404
[TBL] [Abstract][Full Text] [Related]
19. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
[TBL] [Abstract][Full Text] [Related]
20. Is COVID-19 infection more severe in kidney transplant recipients?
Caillard S; Chavarot N; Francois H; Matignon M; Greze C; Kamar N; Gatault P; Thaunat O; Legris T; Frimat L; Westeel PF; Goutaudier V; Jdidou M; Snanoudj R; Colosio C; Sicard A; Bertrand D; Mousson C; Bamoulid J; Masset C; Thierry A; Couzi L; Chemouny JM; Duveau A; Moal V; Blancho G; Grimbert P; Durrbach A; Moulin B; Anglicheau D; Ruch Y; Kaeuffer C; Benotmane I; Solis M; LeMeur Y; Hazzan M; Danion F;
Am J Transplant; 2021 Mar; 21(3):1295-1303. PubMed ID: 33259686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
